Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy

被引:58
作者
Hallak, M
Senderowicz, J
Cassel, A
Shapira, C
Aghai, E
Auslender, R
Abramovici, H
机构
[1] WAYNE STATE UNIV,SCH MED,DETROIT,MI
[2] CARMEL HOSP,DEPT OBSTET & GYNECOL,HAIFA,ISRAEL
[3] CARMEL HOSP,DEPT HEMATOL,HAIFA,ISRAEL
[4] CARMEL HOSP,DEPT CARDIOL,HAIFA,ISRAEL
关键词
factor V Leiden; pregnancy; thrombosis; POOR ANTICOAGULANT RESPONSE; VENOUS THROMBOSIS; MUTATION; BLOOD; THROMBOPHILIA; COFACTOR; THROMBOEMBOLISM; DIAGNOSIS;
D O I
10.1016/S0002-9378(97)70617-3
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our purpose was to evaluate activated protein C resistance phenotype and genotype among patients with thrombosis during pregnancy and the puerperium. STUDY DESIGN: This observational study was conducted prospectively during a 2-year period (July 1993 to June 1995) in a preselected population. All patients admitted to our high-risk pregnancy unit with a diagnosis of deep vein thrombosis, pulmonary emboli, transient ischemic attack, and cerebrovascular accident during pregnancy and the puerperium were included. Prothrombin time, partial thromboplastin time, fibrinogen revels, protein C, protein S, antithrombin III, functional test for activated protein C resistance, and factor V Leiden mutation by polymerase chain reaction were performed on each patient. RESULTS: Fifteen patients were included. Seven (46.6%) patients were positive for activated protein C resistance (factor V Leiden). All other coagulation studies were negative for all patients. All patients with activated protein C resistance had a venous thrombotic event, deep vein thrombosis, or pulmonary emboli, and only one had a cerebrovascular accident on the basis of sagittal sinus thrombosis. Only two of the activated protein C resistance-negative patients had venous thrombosis (pulmonary emboli). The remaining six patients had transient ischemic attacks or cerebrovascular accidents. For the subgroup with venous thrombosis during pregnancy and the puerperium, the incidence of activated protein C resistance (factor V Leiden) was 78%. CONCLUSION: This study demonstrates the incidence of factor V Leiden in a selected population in whom thrombotic events developed during pregnancy and the puerperium. This small-scale study provides justification for a large cohort study that will identify women with factor V Leiden and determine their risk for thrombosis during pregnancy and the puerperium. We believe that factor V Leiden should be evaluated in conjunction with thrombotic events in the pregnant woman.
引用
收藏
页码:889 / 893
页数:5
相关论文
共 21 条
[1]   DIAGNOSIS OF ACTIVATED PROTEIN-C RESISTANCE (FACTOR-V LEIDEN) [J].
BAKER, R ;
THOM, J ;
VANBOCKXMEER, F .
LANCET, 1994, 344 (8930) :1162-1162
[2]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[3]   FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C [J].
DAHLBACK, B ;
CARLSSON, M ;
SVENSSON, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1004-1008
[4]   INHERITED RESISTANCE TO ACTIVATED PROTEIN-C IS CORRECTED BY ANTICOAGULANT COFACTOR ACTIVITY FOUND TO BE A PROPERTY OF FACTOR-V [J].
DAHLBACK, B ;
HILDEBRAND, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1396-1400
[5]  
DERONDE H, 1994, THROMB HAEMOSTASIS, V72, P880
[6]  
FAIONI EM, 1993, THROMB HAEMOSTASIS, V70, P1067
[7]   VARIABILITY OF THROMBOSIS AMONG HOMOZYGOUS SIBLINGS WITH RESISTANCE TO ACTIVATED PROTEIN-C DUE TO AN ARG-]GLN MUTATION IN THE GENE FOR FACTOR-V [J].
GREENGARD, JS ;
EICHINGER, S ;
GRIFFIN, JH ;
BAUER, KA .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (23) :1559-1562
[8]   ACTIVATED PROTEIN-C RESISTANCE CAUSED BY ARG506GLN MUTATION IN FACTOR VA [J].
GREENGARD, JS ;
SUN, X ;
XU, X ;
FERNANDEZ, JA ;
GRIFFIN, JH ;
EVATT, B .
LANCET, 1994, 343 (8909) :1361-1362
[9]  
GRIFFIN JH, 1993, BLOOD, V82, P1989
[10]   MODIFIED TEST FOR ACTIVATED PROTEIN-C RESISTANCE [J].
JORQUERA, JI ;
MONTORO, JM ;
FERNANDEZ, MA ;
AZNAR, JA ;
AZNAR, J .
LANCET, 1994, 344 (8930) :1162-1163